174
Views
1
CrossRef citations to date
0
Altmetric
Strabismus and Extraocular Anatomy

Lacrimal Gland and Orbital Lesions in LatY136F Knock-in Mice, a Model for Human IgG4-Related Ophthalmic Disease

, , , , , , , , & show all
Pages 1402-1409 | Received 21 Jul 2021, Accepted 13 Jul 2022, Published online: 01 Aug 2022

References

  • Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, Fukushima M, Nikaido T, Nakayama K, Usuda N, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344(10):732–738. doi:10.1056/NEJM200103083441005.
  • Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Yoshino T, Nakamura S, Kawa S, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22(1):21–30. doi:10.3109/s10165-011-0571-z.
  • Stone JH, Khosroshahi A, Deshpande V, Chan JK, Heathcote JG, Aalberse R, Azumi A, Bloch DB, Brugge WR, Carruthers MN, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64(10):3061–3067. doi:10.1002/art.34593.
  • Yamada K, Yamamoto M, Saeki T, Mizushima I, Matsui S, Fujisawa Y, Hara S, Takahashi H, Nomura H, Kawa S, et al. New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases. Arthritis Res Ther. 2017;19(1):262. doi:10.1186/s13075-017-1467-x.
  • Goto H, Takahira M, Azumi A. Diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol. 2015;59(3):201– 207. doi:10.1007/s10384-014-0352-2.
  • Sogabe Y, Ohshima K, Azumi A, Takahira M, Kase S, Tsuji H, Yoshikawa H, Nakamura T. Location and frequency of lesions in patients with IgG4-related ophthalmic diseases. Graefes Arch Clin Exp Ophthalmol. 2014;252(3):531–538. doi:10.1007/s00417-013-2548-4.
  • Masaki Y, Kurose N, Umehara H. IgG4-related disease: a novel lymphoproliferative disorder discovered and established in Japan in the 21st century. J Clin Exp Hematop. 2011;51(1):13–20. doi:10.3960/jslrt.51.13.
  • Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine. 2012;91(1):57–66. doi:10.1097/MD.0b013e3182431ef6.
  • Ebbo M, Grados A, Samson M, Groh M, Loundou A, Rigolet A, Terrier B, Guillaud C, Carra-Dallière C, Renou F, et al. Long-term efficacy and safety of rituximab in IgG4-related disease: data from a French nationwide study of thirty-three patients. PLOS One. 2017;12(9):e0183844. doi:10.1371/journal.pone.0183844.
  • Aguado E, Richelme S, Nuñez-Cruz S, Miazek A, Mura AM, Richelme M, Guo XJ, Sainty D, He HT, Malissen B, et al. Induction of T helper type 2 immunity by a point mutation in the LAT adaptor. Science. 2002;296(5575):2036–2040. doi:10.1126/science.1069057.
  • Genton C, Wang Y, Izui S, Malissen B, Delsol G, Fournié GJ, Malissen M, Acha-Orbea H. The Th2 lymphoproliferation developing in LatY136F mutant micetriggers polyclonal B cell activation and systemic autoimmunity. J Immunol. 2006;177(4):2285–2293. doi:10.4049/jimmunol.177.4.2285.
  • Yamada K, Zuka M, Ito K, Mizuguchi K, Kakuchi Y, Onoe T, Suzuki Y, Yamagishi M, Izui S, Malissen M, et al. LatY136F knock-in mouse model for human IgG4-related disease. PLOS One. 2018;13(6):e0198417. doi:10.1371/journal.pone.0198417.
  • Cheuk W, Chan JK. IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol. 2010;17(5):303–332. doi:10.1097/PAP.0b013e3181ee63ce.
  • Takahira M, Kawano M, Zen Y, Minato H, Yamada K, Sugiyama K. IgG4-related chronic sclerosing dacryoadenitis. Arch Ophthalmol. 2007; 125(11):1575–1578. doi:10.1001/archopht.125.11.1575.
  • Kubota T, Moritani S, Sakuma M. Tarsal IgG4-related disease. JAMA Ophthalmol. 2015;133(2):e143272. doi:10.1001/jamaophthalmol.2014.3272.
  • Verhoekx JSN, Karim AF, van Laar JAM, Verdijk RM, Paridaens D. The tarsal plate manifestation of IgG4-related disease. Int Ophthalmol. 2019; 39(7):1613–1615. doi:10.1007/s10792-018-0974-3.
  • Leivo T, Koskenmies S, Uusitalo M, Tynninen O. IgG4-related disease mimicking chalazion in the upper eyelid with skin manifestations on the trunk. Int Ophthalmol. 2015;35(4):595–597. doi:10.1007/s10792-015-0070-x.
  • Cheuk W, Yuen HK, Chan JK. Complication of IgG4-related chronic sclerosing dacryoadenitis by lymphoma. Arch Ophthalmol. 2008;126(8):1170. doi:10.1001/archopht.126.8.1170-a.
  • Japanese study group of IgG4-related ophthalmic disease. A prevalence study of IgG4-related ophthalmic disease in Japan. Jpn J Ophthalmol. 2013;57(6):573–579.
  • Sato Y, Takata K, Ichimura K, Tanaka T, Morito T, Tamura M, Yoshino T. IgG4-producing marginal zone B-cell lymphoma. Int J Hematol. 2008;88(4):428–433. doi:10.1007/s12185-008-0170-8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.